Brandon Folkes

Stock Analyst at HC Wainwright & Co.

(3.67)
# 2513
Out of 5,456 analysts
96
Total ratings
Success rate
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
ACHV Achieve Life Science...
Initiates Coverage On: Buy
12
2.92 310.96% 2 Aug 21, 2025
EPRX Eupraxia Pharmaceuti...
Reiterates: Buy
12 12
5.31 125.99% 3 Aug 20, 2025
GNFT Genfit
Assumes: Buy
9
4.32 108.33% 1 Aug 19, 2025
VALN Valneva
Assumes: Buy
18
11.57 55.57% 1 Aug 19, 2025
PYPD PolyPid
Reiterates: Buy
13 13
3.5 271.43% 4 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
1.83 282.51% 2 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
10
7.75 29.03% 1 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
44
39.11 12.5% 6 Aug 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
84 93
91.01 2.19% 5 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 17
13.69 24.18% 3 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
29
7.11 307.88% 1 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
24.32 15.13% 1 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
20
8.83 126.5% 1 Jul 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
9
4.11 118.98% 2 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
9.44 175.42% 1 Jul 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.4 328.57% 2 Jun 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
5
1.7 194.12% 2 Jun 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
1.17 669.23% 1 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
7.55 178.15% 2 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.14 338.6% 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
4.4 104.55% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
9.24 73.16% 6 Sep 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
0.62 1512.9% 2 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
455
18.87 2311.23% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
59
33.95 73.78% 4 Sep 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8
1.49 436.91% 4 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
180
123.11 46.21% 2 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 15
14.7 0.34% 2 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
300 220
3.6 6011.11% 3 Dec 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
5
n/a n/a 1 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
6
n/a n/a 1 Jun 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
7.47 20.48% 1 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
28 32
29.75 7.56% 3 Jan 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
40
0.82 4778.05% 1 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
22000
n/a n/a 1 Aug 31, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
3125
n/a n/a 1 Aug 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
38 53
n/a n/a 4 Aug 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
405 315
9.6 3181.25% 3 Mar 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 46
n/a n/a 6 Mar 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 42
20.65 103.39% 2 Sep 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 50
15.66 219.28% 1 Jul 12, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
7 4
n/a n/a 2 Mar 13, 2018